Indeed, patients with SARS-CoV-2, especially those with severe pneumonia, have a dysregulated immune response at hospitalization and often develop immune suppression characterized by lymphopenia, mainly in CD4 and CD8 T cells after the pro-inflammatory phase [30]. The gene discussed is CD4; the disease is pneumonia.